Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 14/05/2012
PIL KOGENATE Bayer 1000 IU Powder and solvent for solution for injection. (Medimop)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
  • Change to side-effects
Updated on 02/05/2012 and displayed until 14/05/2012
Reasons for adding or updating:
  • PIL Retired pending re-submission
  • Change to date of revision
  • Change to storage instructions
  • Change to side-effects
Updated on 17/04/2012 and displayed until 02/05/2012
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to side-effects
Updated on 07/07/2011 and displayed until 17/04/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 19/01/2011 and displayed until 07/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
Updated on 11/08/2010 and displayed until 19/01/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to appearance of the medicine
  • Change to packaging
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Extra statutory information
Updated on 10/06/2010 and displayed until 11/08/2010
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  octocog alfa